AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go

AbbVie and Allergan have waited for nearly a year for their much-discussed merger to pass muster. But finally, after pushback from consumer groups and tight scrutiny from regulators, the Federal Trade Commission has granted the megadeal a green light.